Biblio

Author Title [ Type

] Year

Filters: Author is Mengarelli, Andrea [Clear All Filters]

Journal Article

Cordone I, Masi S, Carosi M, Vidiri A, Marchesi F, Marino M, Telera S, Pasquale A, Mengarelli A, Conti L, et al. Brain stereotactic biopsy flow cytometry for central nervous system lymphoma characterization: advantages and pitfalls. J Exp Clin Cancer Res. 2016;35(1):128.

Maschio M, Marchesi F, Dispenza S, Dinapoli L, Sperati F, Petreri G, Gumenyuk S, Dessanti MLaura, Zarabla A, Cantelmi T, et al. Effect of high dose cytosine arabinoside on quantitative EEG in patients with acute myeloid leukemia. Cogn Neurodyn. 2016;10(2):185-188.

Marchesi F, Terrenato I, Papa E, Tomassi M, Falcucci P, Gumenyuk S, Palombi F, Pisani F, Renzi D, Romano A, et al. Efficacy and safety of biosimilar Peg-filgrastim after autologous stem cell transplant in myeloma and lymphoma patients: a comparative study with biosimilar Filgrastim, Lenograstim, and originator Peg-filgrastim. Ann Hematol. 2024.

Travaglini S, Gurnari C, Antonelli S, Marchesi F, De Angelis G, Ottone T, Divona M, Cristiano A, Hajrullaj H, Mengarelli A, et al. Functional characterization and response to FLT3 inhibitors in acute myeloid leukaemia with a non-canonical FLT3 mutation: A proof of concept. Br J Haematol. 2023.

Marchesi F, Girmenia C, Goffredo BMaria, Salvatorelli E, Romano A, Mengarelli A, Minotti G, Menna P. Isavuconazole: Case Report and Pharmacokinetic Considerations. Chemotherapy. 2018;63(5):253-256.

Arcese W, Cerretti R, Sarmati L, Cudillo L, De Angelis G, Mariotti B, Bruno A, Mangione I, Rapanotti C, Andreani M, et al. MATCHED-PAIR ANALYSIS OF TRANSPLANT FROM HAPLOIDENTICAL, UNMANIPULATED BONE MARROW DONOR VERSUS HLA IDENTICAL SIBLING FOR PATIENTS WITH HEMATOLOGICAL MALIGNANCIES. Biol Blood Marrow Transplant. 2020.

Mina R, Petrucci MTeresa, Bonello F, Bongarzoni V, Saccardi R, Bertuglia G, Mengarelli A, Spadaro A, Lisi C, Curci P, et al. A prospective, multicenter study on hematopoietic stem-cell mobilization with cyclophosphamide plus granulocyte colony-stimulating factor and 'on-demand' plerixafor in multiple myeloma patients treated with novel agents. Haematologica. 2023.

Maschio M, Mengarelli A, Zarabla A, Giannarelli D, Maialetti A, Gumenyuk S, Renzi D, Palombi F, Pisani F, Romano A, et al. Role of Pregabalin in Treatment of Polyneuropathy in Multiple Myeloma Patients: A Retrospective Study. Clin Neuropharmacol. 2019.